vs
FENNEC PHARMACEUTICALS INC.（FENC）与Forian Inc.（FORA）财务数据对比。点击上方公司名可切换其他公司
FENNEC PHARMACEUTICALS INC.的季度营收约是Forian Inc.的1.7倍（$13.8M vs $8.0M），Forian Inc.净利率更高（-22.9% vs -34.7%，领先11.9%），FENNEC PHARMACEUTICALS INC.同比增速更快（73.8% vs 37.0%），过去两年Forian Inc.的营收复合增速更高（27.8% vs -26.3%）
Fennec制药是一家生物制药企业，专注于开发和商业化可降低儿童癌症患者治疗相关副作用的特种疗法，核心产品针对化疗引发的耳毒性，主要市场覆盖北美，服务肿瘤诊疗机构及儿童肿瘤患者群体。
Forian Inc是一家专注于医疗健康领域的数据分析与技术服务商，提供SaaS模式的真实世界证据解决方案、临床决策支持工具及运营优化服务，客户覆盖生物制药企业、医疗机构及生命科学领域相关机构，助力提升诊疗效率、推动医学研究进展。
FENC vs FORA — 直观对比
营收规模更大
FENC
是对方的1.7倍
$8.0M
营收增速更快
FENC
高出36.9%
37.0%
净利率更高
FORA
高出11.9%
-34.7%
两年增速更快
FORA
近两年复合增速
-26.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.8M | $8.0M |
| 净利润 | $-4.8M | $-1.8M |
| 毛利率 | — | 49.2% |
| 营业利润率 | -18.5% | -24.4% |
| 净利率 | -34.7% | -22.9% |
| 营收同比 | 73.8% | 37.0% |
| 净利润同比 | -141.1% | -1012.2% |
| 每股收益（稀释后） | $-0.17 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FENCFORA
| Q4 25 | $13.8M | $8.0M | ||
| Q3 25 | $12.5M | $7.8M | ||
| Q2 25 | $9.7M | $7.5M | ||
| Q1 25 | $8.8M | $7.1M | ||
| Q4 24 | $7.9M | $5.8M | ||
| Q3 24 | $7.0M | $4.7M | ||
| Q2 24 | $7.3M | $4.8M | ||
| Q1 24 | $25.4M | $4.9M |
净利润FENCFORA
| Q4 25 | $-4.8M | $-1.8M | ||
| Q3 25 | $-638.0K | $-151.2K | ||
| Q2 25 | $-3.2M | $224.8K | ||
| Q1 25 | $-1.2M | $-1.1M | ||
| Q4 24 | $-2.0M | $199.7K | ||
| Q3 24 | $-5.7M | $-204.9K | ||
| Q2 24 | $-5.6M | $-2.6M | ||
| Q1 24 | $12.8M | $-1.2M |
毛利率FENCFORA
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 51.6% | ||
| Q2 25 | — | 56.8% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 58.3% | ||
| Q3 24 | — | 70.1% | ||
| Q2 24 | — | 62.2% | ||
| Q1 24 | — | 65.1% |
营业利润率FENCFORA
| Q4 25 | -18.5% | -24.4% | ||
| Q3 25 | -1.5% | -6.1% | ||
| Q2 25 | -28.3% | 0.6% | ||
| Q1 25 | -9.2% | -19.8% | ||
| Q4 24 | -11.8% | -24.9% | ||
| Q3 24 | -74.6% | -17.0% | ||
| Q2 24 | -69.4% | -62.2% | ||
| Q1 24 | 54.2% | -36.3% |
净利率FENCFORA
| Q4 25 | -34.7% | -22.9% | ||
| Q3 25 | -5.1% | -1.9% | ||
| Q2 25 | -32.7% | 3.0% | ||
| Q1 25 | -13.3% | -16.0% | ||
| Q4 24 | -25.0% | 3.4% | ||
| Q3 24 | -82.2% | -4.4% | ||
| Q2 24 | -76.5% | -53.4% | ||
| Q1 24 | 50.6% | -24.9% |
每股收益（稀释后）FENCFORA
| Q4 25 | $-0.17 | $-0.06 | ||
| Q3 25 | $-0.02 | $0.00 | ||
| Q2 25 | $-0.11 | $0.01 | ||
| Q1 25 | $-0.04 | $-0.04 | ||
| Q4 24 | $-0.02 | $0.01 | ||
| Q3 24 | $-0.21 | $-0.01 | ||
| Q2 24 | $-0.20 | $-0.08 | ||
| Q1 24 | $0.41 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $36.8M | $31.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $35.5M | $29.8M |
| 总资产 | $70.6M | $44.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FENCFORA
| Q4 25 | $36.8M | $31.6M | ||
| Q3 25 | $21.9M | $28.2M | ||
| Q2 25 | $18.7M | $35.6M | ||
| Q1 25 | $22.7M | $35.7M | ||
| Q4 24 | $26.6M | $35.1M | ||
| Q3 24 | $40.3M | $49.4M | ||
| Q2 24 | $43.1M | $48.0M | ||
| Q1 24 | $51.2M | $47.4M |
总债务FENCFORA
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | — | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | — | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
股东权益FENCFORA
| Q4 25 | $35.5M | $29.8M | ||
| Q3 25 | $-4.5M | $31.1M | ||
| Q2 25 | $-7.5M | $30.9M | ||
| Q1 25 | $-5.9M | $30.0M | ||
| Q4 24 | $-5.9M | $30.1M | ||
| Q3 24 | $-5.2M | $28.4M | ||
| Q2 24 | $-1.4M | $27.2M | ||
| Q1 24 | $3.0M | $28.1M |
总资产FENCFORA
| Q4 25 | $70.6M | $44.1M | ||
| Q3 25 | $49.3M | $41.3M | ||
| Q2 25 | $44.9M | $48.5M | ||
| Q1 25 | $46.4M | $48.6M | ||
| Q4 24 | $44.9M | $47.2M | ||
| Q3 24 | $58.9M | $57.5M | ||
| Q2 24 | $63.2M | $58.4M | ||
| Q1 24 | $69.2M | $57.5M |
负债/权益比FENCFORA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.0M | $3.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FENCFORA
| Q4 25 | $-6.0M | $3.2M | ||
| Q3 25 | $1.5M | $-439.7K | ||
| Q2 25 | $-3.7M | $-344.5K | ||
| Q1 25 | $-4.3M | $448.2K | ||
| Q4 24 | $-1.5M | $1.7M | ||
| Q3 24 | $-2.2M | $764.1K | ||
| Q2 24 | $-8.4M | $-23.1K | ||
| Q1 24 | $39.0M | $-2.2M |
资本支出强度FENCFORA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率FENCFORA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.53× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 8.76× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.04× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FENC
暂无分部数据
FORA
| Financial Services Revenues | $7.3M | 92% |
| Other | $669.0K | 8% |
